L Harlaar
Overview
Explore the profile of L Harlaar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van den Dorpel J, Poelman E, Harlaar L, van Kooten H, van der Giessen L, van Doorn P, et al.
Orphanet J Rare Dis
. 2020 Sep;
15(1):247.
PMID: 32928284
Background: Enzyme replacement therapy (ERT; alglucosidase alfa) has improved the prospects for patients with classic infantile Pompe disease considerably. However, over time we noticed that many of these children exhibit...
2.
van Kooten H, Harlaar L, van der Beek N, van Doorn P, van der Ploeg A, Brusse E
Neuromuscul Disord
. 2020 Jan;
30(1):59-66.
PMID: 31911071
Enzyme replacement therapy for Pompe disease received market authorization in 2006. To implement this costly treatment in the Netherlands in the most sensible way, a multidisciplinary expert committee was installed....
3.
Harlaar L, Ciet P, van der Ploeg A, Brusse E, van der Beek N, Wielopolski P, et al.
Neuromuscul Disord
. 2018 Feb;
28(3):246-256.
PMID: 29398294
Respiratory muscle weakness frequently occurs in patients with neuromuscular disease. Measuring respiratory function with standard pulmonary function tests provides information about the contribution of all respiratory muscles, the lungs and...